慢性腎不全の体積過負荷児の血におけるアトリアルナトリウレチンペプチド
Lancet (London, England)
|August 10, 1985
まとめ
慢性腎不全の小児では,心房内ナトリウレチンペプチド (ANP) 濃度の上昇は,細胞外流体量の増加と関連しています. これは,ANPがこれらの患者の液体バランスの維持に重要な役割を果たしていることを示唆しています.
科学分野:
- 小児腎臓病理学について
- エンドクリノロジー エンドクリノロジー
- 心血管生理学 心血管の生理学
背景:
- 慢性腎不全の子供は,しばしば液体体積の不均衡を経験します.
- アトリアルナトリウレチンペプチド (ANP) は,体液レベルを調節するホルモンです.
研究 の 目的:
- 慢性腎不全の小児患者の体積状態とプラズマANP濃度との関係を調査する.
- 末期腎疾患 (ESRD) での液体ホメオスタシスにおけるANPの役割を理解する.
主な方法:
- 特定の,敏感な放射性免疫測定法を使用して,血のANPレベルを測定しました.
- ESRD,進行性腎不全の子供と健康な対照群のANPレベルを比較した.
- 血液透析中のANPの変化をモニタリングし,体重増加と相関させました.
主要な成果:
- 前透析のプラズマANPは,ESRDの子どもでは,対照群と比較して有意に高かった.
- 血のANPは,血液透析中に著しく低下した.
- プラズマANPは体量状態と正の相関を示し,体重増加によって示された.
結論:
- 拡張された細胞外流体量は,ESRDの小児のANP上昇の主な刺激である.
- ANPは,小児慢性腎不全における体積ホメオスタシスの維持に不可欠であるようです.
関連する概念動画
Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...


